Radiation‐induced lung injury (RILI) frequently occurs in patients with thoracic malignancies. In response to radiation, alveolar epithelial cells (AEC) undergo epithelial‐mesenchymal transition (EMT) and contribute to the pathogenesis of RILI.… Click to show full abstract
Radiation‐induced lung injury (RILI) frequently occurs in patients with thoracic malignancies. In response to radiation, alveolar epithelial cells (AEC) undergo epithelial‐mesenchymal transition (EMT) and contribute to the pathogenesis of RILI. Insulin‐like growth factor binding protein 7 (IGFBP7) is reported as a downstream mediator of transforming growth factor‐β1 (TGF‐β1) pathway, which plays a crucial role in radiation‐induced EMT. In the present study, the levels of IGFBP7 and TGF‐β1 were simultaneously increased in experimental RILI models and radiation‐treated AEC (human pulmonary alveolar epithelial cells [HPAEpic]). The expression of IGFBP7 in radiation‐treated HPAEpic cells was obviously inhibited by the specific inhibitor of TGF‐β receptor antagonist SB431542 and TGF‐β1 neutralizing antibody, and time‐dependently enhanced by TGF‐β1 treatment. Moreover, IGFBP7 knockdown significantly attenuated the effects of radiation on morphology change, cell migration, expression of EMT‐related markers (E‐cadherin, α‐SMA, and Vimentin), and phosphorylation of extracellular‐signal‐regulated kinase (ERK). The effects of IGFBP7 overexpression on the expression of EMT‐related markers were partially reversed by the ERK inhibitor PD98059. In conclusion, IGFBP7, was enhanced by TGF‐β1, may be involved in radiation‐induced EMT of AEC via the ERK signaling pathway, thus contributing to the pathogenesis of RILI.
               
Click one of the above tabs to view related content.